Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

Record identifier

TN_cdi_proquest_journals_2552991645

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552991645

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

Full title

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2020, Vol.8 (1), p.e000530

Record Identifier

TN_cdi_proquest_journals_2552991645

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2552991645

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552991645

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card